Kato GJ, Piel FB, Reid CD et al (2018) Sickle cell disease. Nat Rev Dis Prim 4:18010

Article  PubMed  Google Scholar 

Piel FB, Williams TN (2017) Subphenotypes of sickle cell disease in Africa. Blood 130(20):2157–2158

Article  PubMed  CAS  Google Scholar 

CDC (2016) Sickle cell disease. [cited 2016; Available from: http://www.cdc.gov/ncbddd/sicklecell/data.html. Accessed 09/08/2023

Steinberg MH (2008) Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. Sci World J 8:1295–1324

Article  Google Scholar 

Carbonare LD, Matte’ A, Valenti MT et al (2015) Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease. Blood 126(20):2320–2328

Article  Google Scholar 

Buison AM, Kawchak DA, Schall JI et al (2005) Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics 116(4):943–949

Article  PubMed  Google Scholar 

Zemel BS, Kawchak DA, Ohene-Frempong K, Schall JI, Stallings VA (2007) Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res 61(5 Pt 1):607–613

Article  PubMed  Google Scholar 

Osunkwo I (2013) An update on the recent literature on sickle cell bone disease. Curr Opin Endocrinol Diabetes Obes 20(6):539–546

Article  PubMed  CAS  Google Scholar 

Almeida A, Roberts I (2005) Bone involvement in sickle cell disease. Br J Haematol 129(4):482–490

Article  PubMed  Google Scholar 

Teti A, Teitelbaum SL (2019) Congenital disorders of bone and blood. Bone 119:71–81

Article  PubMed  Google Scholar 

Grimbly C, Escagedo PD, Jaremko J et al (2022) Sickle cell bone disease and response to intravenous bisphosphonates in children. Osteoporos Int 33(11):2397–2408

De Franceschi L, Gabbiani D, Giusti A et al (2020) Development of algorithm for clinical management of sickle cell bone disease: evidence for a role of vertebral fractures in patient follow-up. J Clin Med 9(5):1601. https://doi.org/10.3390/jcm9051601

Adesina OO, Neumayr LD (2019) Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management. Hematol Am Soc Hematol Educ Program 2019(1):351–358

Article  Google Scholar 

Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP (2006) Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer 47(7):901–906

Article  PubMed  Google Scholar 

Meeuwes M, Souza de Carvalho TF, Cipolotti R et al (2013) Bone mineral density, growth, pubertal development and other parameters in Brazilian children and young adults with sickle cell anaemia. Trop Med Int Health 18(12):1539–46

Article  PubMed  CAS  Google Scholar 

Adams-Graves P, Daniels AB, Womack CR, Freire AX (2014) Bone mineral density patterns in vitamin D deficient African American men with sickle cell disease. Am J Med Sci 347(4):262–266

Article  PubMed  Google Scholar 

Sarrai M, Duroseau H, D’Augustine J, Moktan S, Bellevue R (2007) Bone mass density in adults with sickle cell disease. Br J Haematol 136(4):666–672

Article  PubMed  CAS  Google Scholar 

Baldanzi G, Traina F, Marques Neto JF et al (2011) Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease. Clinics (Sao Paulo, Brazil) 66(5):801–5

Article  PubMed  Google Scholar 

Spinola-Castro AM, Siviero-Miachon AA (2014) Low bone mineral density in patients with sickle cell anaemia (SCA) and short stature should be interpreted with caution. Trop Med Int Health: TM IH 19(3):364–365

Article  PubMed  Google Scholar 

Adesina OO, Gurney JG, Kang G et al (2019) Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results. Blood Adv 3(9):1476–1488

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hankins JS, Estepp JH, Hodges JR et al (2018) Sickle Cell Clinical Research and Intervention Program (SCCRIP): a lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood. Pediatr Blood Cancer 65(9):e27228

Article  PubMed  Google Scholar 

Dampier C, Palermo TM, Darbari DS et al (2017) AAPT diagnostic criteria for chronic sickle cell disease pain. J Pain 18(5):490–498

Article  PubMed  Google Scholar 

Brandow AM, Carroll CP, Creary S et al (2020) American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv 4(12):2656–2701

Article  PubMed  PubMed Central  Google Scholar 

Ballas SK, Kesen MR, Goldberg MF et al (2012) Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal 2012:949535

Article  PubMed  PubMed Central  Google Scholar 

Mandese V, Bigi E, Bruzzi P et al (2019) Endocrine and metabolic complications in children and adolescents with sickle cell disease: an Italian cohort study. BMC Pediatr 19(1):56

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yawn BP, Buchanan GR, Afenyi-Annan AN et al (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312(10):1033–1048

Article  PubMed  Google Scholar 

Shepherd JA (2023) Positions of The international society for clinical densitometry and their etiology: a scoping review. J Clin Densitom 26(3):101369

Article  PubMed  Google Scholar 

Masese RV, Bulgin D, Knisely MR et al (2021) Sex-based differences in the manifestations and complications of sickle cell disease: report from the sickle cell disease implementation consortium. PLoS One 16(10):e0258638

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gallo AM, Patil C, Adeniyi T et al (2019) Health-related quality of life and personal life goals of adults with sickle cell disease after hematopoietic stem cell transplantation. West J Nurs Res 41(4):555–575

Article  PubMed  Google Scholar 

Coxon FP, Thompson K, Rogers MJ (2006) Recent advances in understanding the mechanism of action of bisphosphonates. Curr Opin Pharmacol 6(3):307–312

Article  PubMed  CAS  Google Scholar 

Cico TB, Kullolli S, Harizi I et al (2013) SAT0381 The use of bisphosphonates in the treatment of low bone mineral density in adults with sickle cell anemia. Ann Rheum Dis 71(Suppl 3):600–601

Google Scholar 

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994) Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129

Google Scholar 

Eastell R, Rosen CJ, Black DM et al (2019) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622

Article  PubMed  Google Scholar 

Santo AH (2022) Sickle cell disease related mortality in Brazil, 2000–2018. Hematol Transfus Cell Ther 44(2):177–185

Article  PubMed  Google Scholar 

Jeney V (2017) Clinical impact and cellular mechanisms of iron overload-associated bone loss. Front Pharmacol 8(FEB):77

PubMed  PubMed Central  Google Scholar 

Valderrábano RJ, Wu JY (2019) Bone and blood interactions in human health and disease. Bone 119:65–70

Article  PubMed  Google Scholar 

Gollamudi J, Karkoska KA, Gbotosho OT et al (2023) A bone to pick-cellular and molecular mechanisms of bone pain in sickle cell disease. Front Pain Res (Lausanne) 4:1302014

Article  PubMed  Google Scholar 

FOSAMAX® (Package Insert) (2015) Merck and Co., I.W.S., NJ:2015

Bolarin DM, Azinge EC (2010) Osteocalcin and specific markers of bone resorption in sickle cell disease. Acta Physiol Hung 97(3):290–296

Article  PubMed  CAS